Why Is Ingrezza So Hard to Find? [Explained for 2026]

If you or a loved one has been prescribed Ingrezza (valbenazine) and you're struggling to fill it, you're not alone. Unlike most medications, Ingrezza is not available at your neighborhood CVS, Walgreens, or Walmart pharmacy. It's a specialty drug with a unique distribution model — and that's the main reason patients run into trouble. This guide explains exactly why Ingrezza is hard to find and what you can do about it.

Is Ingrezza in Short Supply or on the FDA Shortage List?

As of 2026, Ingrezza is NOT on the FDA's official drug shortage list. The difficulty patients experience filling Ingrezza is not because of a manufacturing shortage — it's because of how the drug is intentionally distributed. Neurocrine Biosciences, the maker of Ingrezza, has designed it as a specialty pharmacy product. That means it bypasses standard retail pharmacies entirely.

So if you go to your local pharmacy and ask for Ingrezza, they will almost certainly tell you they don't carry it — and they're telling the truth. It's not because it's out of stock. It's because it was never sent to them in the first place.

Why Is Ingrezza Only Available at Specialty Pharmacies?

Ingrezza is a high-cost specialty medication used to treat tardive dyskinesia (TD) and chorea associated with Huntington's disease. Specialty pharmacies are equipped to handle these types of drugs because they can provide:

Insurance prior authorization support

Patient financial assistance enrollment (like the INBRACE Savings Card)

Clinical monitoring and care coordination

Direct home delivery of medication

Neurocrine has built the Neurocrine Access Support program specifically to funnel Ingrezza through a select network of specialty and local affiliated pharmacies. When your doctor submits the INGREZZA Treatment Form, it serves as both the prescription and an enrollment into this support program — and the medication is shipped directly to you.

The Biggest Barrier: Prior Authorization

Even once you've sorted out the specialty pharmacy issue, prior authorization (PA) is the most common reason patients can't get Ingrezza quickly. Virtually every insurance plan — commercial, Medicare, and Medicaid — requires prior authorization before covering Ingrezza. This means your doctor must submit documentation proving:

A confirmed diagnosis of tardive dyskinesia or Huntington's disease chorea

That the patient is an adult

Possibly that other treatments have been tried (step therapy requirements vary by plan)

The PA process can take days to weeks, which is why many patients experience frustrating delays even after leaving their doctor's office with a prescription. If your insurance denies the PA, you have the right to appeal — and Neurocrine's support team can help with that process.

The High Cost Factor

Ingrezza's retail price is roughly $7,900–$8,700 for a 28-day supply depending on dose strength, making it one of the more expensive medications on the market. There is no generic version available. This price tag is another reason patients run into difficulty: without insurance coverage and the proper savings programs activated, the cost alone makes it out of reach for most people.

The good news: Neurocrine's INBRACE program offers a $0 copay for eligible commercially insured patients, and a Patient Assistance Program that provides the drug at no cost to uninsured patients who qualify financially. Most commercially insured patients pay $10 or less per month.

What Happens If There's an Access Problem at the Specialty Pharmacy?

Occasionally, patients encounter issues even within the specialty pharmacy network — for example, a delay in PA approval, a hiccup with insurance verification, or difficulty reaching their assigned pharmacy. Here's what to do:

Call Neurocrine Access Support directly at 1-844-647-3992 (Monday–Friday, 8 am–8 pm ET).

Ask your prescriber's office to follow up with the specialty pharmacy on the PA status.

Ask about the 30-Day Free Trial (INGREZZA Start Program) to bridge any gap while insurance approval is processed.

Use medfinder to quickly identify which pharmacies in your area can fill your prescription.

How medfinder Can Help You Find Ingrezza

If you're struggling to locate a pharmacy that can actually fill your Ingrezza prescription, medfinder is a service that calls pharmacies on your behalf to find which ones have your medication in stock and can fill your prescription. You provide your medication, dosage, and location — and medfinder handles the calling so you don't have to.

For a detailed step-by-step guide, see our post on how to find Ingrezza in stock near you.

Summary: Why Ingrezza Is Hard to Find

Specialty pharmacy only: Not available at retail pharmacies — must be dispensed through specialty networks.

Prior authorization required: Nearly all insurance plans require PA, causing delays.

High cost without assistance: Retail price $7,900–$8,700/month; savings programs bring this down significantly.

No FDA shortage: The drug exists — it's the distribution and coverage system that creates the access challenge.

Want to learn more about keeping the cost manageable? See our guide on how to save money on Ingrezza in 2026.